Searched for
MYLAN PHARMA
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vialThe DCGI has approved the company's remdesivir 100 mg per vial for restricted emergency use in India as part of the regulator's accelerated...- Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall"We understand from Mylan NV's press release dated January 8, 2020, that Mylan Pharmaceuticals has initiated a voluntary recall of three lo...
- Mylan to invest $1 billion in India on capex in 6 yearsCurrently Mylan has 21 facilities and 15,000 employees working in India.
- Natco will out-license molecules to big pharma: Amit Rajan, Director, Celogen LifeAmit Rajan, Director, Celogen Life says that Micro Labs will quickly come out of the FDA and midcap space as they have a good R&D pipeline.
- Natco Pharma's partner MylanInc gets USFDA nod for cancer drugThe company's marketing partner Mylan Inc has received a tentative approval from the United States Food and Drug Administration (USFDA).
- Govt clears Mylan's takeover of Jai PharmaGovernment approved the proposal of global pharma major Mylan to invest $750 million in its Indian arm to help it acquire Jai Pharma.
- FIPB clears Mylan's Rs 4,960-crore FDI proposalForeign Investment Promotion Board (FIPB) cleared FDI proposal of Mylan Laboratories entailing a capital inflow of Rs 4,960 crore.
- US court finds Teva's Copaxone patent invalid again: Natco PharmaNatco Pharma, a city-based drug maker, today said the US Court of Appeals for Federal Court has again found one of the patents of Teva's Co...
- Teva’s hostile bid for Mylan: Deal could open up a $2-billion opportunity for pharma companiesAccording to experts, there is a possibility that the fruition of the deal will open up a $2-billion opportunity for Indian generic pharma ...
- Mylan may buy contraceptive co Famy Care for Rs 3,000 croreMylan is said to have pipped private equity bids from Bain Capital and Advent to move closer to a deal. Hong Kong-based AIF Capital holds 1...
- Venus Remedies shares up as unit enters into pact with MylanIn terms of volume, 3.14 lakh shares of the company changed hands at the BSE, while over 11 lakh shares were traded at the NSE during the d...
- Natco Pharma's partner Mylan Inc files ANDA for generic CopaxoneAccording to IMS health, Copaxone 40 mg/mL had US sales of nearly USD 411.5 million for the 12 months ending June 30, 2014, it added.
- Mylan’s Agila Specialties deal faces riders from US watchdogUS-based generic giant Mylan Inc’s $1.85-billion bid to acquire Indian drugmaker Agila Specialties now faces fresh riders, this time from i...
- Govt clears Mylan's Rs 5,168-cr deal to acquire Agila SpecialtiesThe decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...
- Strides Arcolab surges over 7 pc as FIPB clears Mylan's FDI proposalSince Mylan's investment proposal is of over Rs 1,200 crore, it will go to the Cabinet Committee on Economic Affairs for final approval.
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...
- CCI gives green signal to Mylan-Unichem dealIt observed that the proposed acquisition by Mylan was with the intent to export products to be manufactured at the said facility.
- Settlement of Somaxon Pharmaceuticals patent suit in US soon: ZydusAhmedabad-based Zydus Cadila says, it agreed to settle a patent litigation suit with US-based Somaxon Pharmaceuticals for insomnia drug – S...
- Natco Pharma soars on drug licensing dealNatco Pharma rose as much as 19 per cent after it struck a licensing and supply deal with US-based Mylan for its generic version of multipl...
- US pharma major Mylan buys Matrix LabsThe generic drugs major will acquir Hyderabad-based Matix Lab in a cash-and-stock deal worth Rs 3,424 cr.
Load More
